Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]

NCT02104063 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT02104063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02104063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Completed
Start date
July 22, 2013
Completion date
July 22, 2016
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of the penis